Canada -
français -
Health Canada
edarbi comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium) - comprimé - 40mg - azilsartan médoxomil (azilsartan médoxomil potassium) 40mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
edarbi comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium) - comprimé - 80mg - azilsartan médoxomil (azilsartan médoxomil potassium) 80mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
edarbyclor comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium); chlorthalidone - comprimé - 40mg; 12.5mg - azilsartan médoxomil (azilsartan médoxomil potassium) 40mg; chlorthalidone 12.5mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
edarbyclor comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium); chlorthalidone - comprimé - 40mg; 25mg - azilsartan médoxomil (azilsartan médoxomil potassium) 40mg; chlorthalidone 25mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
edarbyclor comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium); chlorthalidone - comprimé - 80mg; 12.5mg - azilsartan médoxomil (azilsartan médoxomil potassium) 80mg; chlorthalidone 12.5mg - angiotensin ii receptor antagonists
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
edarbyclor 40 mg/12.5 mg comprimés pelliculés
takeda pharma ag - azilsartanum medoxomilum, chlortalidonum - comprimés pelliculés - azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum, chlortalidonum 12.5 mg, mannitolum, cellulosum microcristallinum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, crospovidonum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), pro compresso obducto corresp. natrium 0.4 mg. - l'hypertension - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
edarbyclor 40 mg/25 mg comprimés pelliculés
takeda pharma ag - azilsartanum medoxomilum, chlortalidonum - comprimés pelliculés - azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum, chlortalidonum 25 mg, mannitolum, cellulosum microcristallinum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, crospovidonum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), pro compresso obducto corresp. natrium 0.4 mg. - l'hypertension - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
edarbi 20mg comprimés
takeda pharma ag - azilsartanum medoxomilum - comprimés - azilsartanum medoxomilum 20 mg ut azilsartanum medoxomilum kalicum 21.34 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 0.80 mg. - essentielle hypertonie - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
edarbi 40mg comprimés
takeda pharma ag - azilsartanum medoxomilum - comprimés - azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum 42.68 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 1.60 mg. - essentielle hypertonie - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
edarbi 80mg comprimés
takeda pharma ag - azilsartanum medoxomilum - comprimés - azilsartanum medoxomilum 80 mg ut azilsartanum medoxomilum kalicum 85.36 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 3.20 mg. - essentielle hypertonie - synthetika